Reprogramming immune cells restoring lives Resetting the energy metabolism of dysfunctional immune cells to conquer disease A breakthrough approach for a broad range of LYSOSOMAL and mitochondrial diseases Tranquis Therapeutics, a trailblazing clinical-stage biopharmaceutical company, is developing a portfolio of small molecule drugs capable of reprogramming dysfunctional cells to restore normal cell homeostasis and function. Our […]
Phone
16506848950
